Dueling Friday night rulings over the legality and availability of mifepristone, also known as the abortion pill, are the most significant turn yet in what’s shaping up to be the biggest fight over reproductive rights in the US since the overturning of Roe v. Wade in June. (Mekelburg, 4/11)
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
USE OUR CONTENT
This story can be republished for free (details).